Samuel C. Blackman Joins Bonum Therapeutics Board of Directors
Key Highlights Samuel C. Blackman, MD, PhD, joins Bonum Therapeutics as an independent director. Blackman is the co-founder…
Browsing Tag
Day One Biopharmaceuticals
1 post